According to Marksans Pharma 's latest financial reports the company's total liabilities are S$0.11 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-03-31 | S$96.19 M | 39.72% |
2023-03-31 | S$68.84 M | -7.49% |
2022-03-31 | S$74.42 M | 25.22% |
2021-03-31 | S$59.43 M | 24.2% |
2020-03-31 | S$47.85 M | -2.26% |
2019-03-31 | S$48.95 M | -3.45% |
2018-03-31 | S$50.7 M | -24.55% |
2017-03-31 | S$67.2 M | 23.79% |
2016-03-31 | S$54.28 M | -14.38% |
2015-03-31 | S$63.4 M | -11.43% |
2014-03-31 | S$71.58 M | 1.73% |
2013-03-31 | S$70.37 M | -48% |
2012-03-31 | S$0.13 B | -13.91% |
2011-03-31 | S$0.15 B | 3.76% |
2010-03-31 | S$0.15 B | 5.32% |
2009-03-31 | S$0.14 B | 2.15% |
2008-03-31 | S$0.14 B | 10.09% |
2007-03-31 | S$0.12 B | 1.47% |
2006-03-31 | S$0.12 B | 149.15% |
2005-03-31 | S$50.59 M |